Health Press Release – Weekly Newsletter for November 15-22, 2010

Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema

RESEARCH TRIANGLE PARK, North Carolina, November 15, 2010 – Talecris Biotherapeutics announced today the publication of combined data
from two studies demonstrating that augmentation therapy with Alpha(1)
-Proteinase Inhibitor (Human) (A1PI) significantly reduces lung tissue loss
in patients with emphysema related to Alpha(1)-antitrypsin (AAT) deficiency.
Results of the studies, published as an integrated analysis of the raw data
from …. Source  : Gaea News Network.

BioWa Announces License of POTELLIGENT(R) Technology to Agensys

PRINCETON, New Jersey, November 15, 2010 – BioWa, Inc. announced today that it has entered into a license agreement
with Agensys, Inc., an affiliate of Tokyo based Astellas Pharma Inc.,
providing Agensys with access to BioWa's POTELLIGENT(R) Technology platform
for the purpose of identifying antibodies with enhanced antibody-dependent
cellular cytotoxicity (ADCC).

"We are extremely pleased …. Source article on Gaea Times at  : BioWa Announces License of POTELLIGENT(R) Technology to Agensys.

Menicon Expands Partnership with Optimed in North America

Menicon exclusively distributes Optimed's innovative patient education software in North America-

NAGOYA, Japan, November 15, 2010 – Menicon Co., Ltd. has announced its agreement with Optimed Ltd. to become
the exclusive distributor for Optimed's CAPTIV8 communication services and
i-Vue content-driven digital signage software for North America. Earlier this
year, Menicon obtained exclusive distribution rights for Optimed's products
in Japan …. Source article  : Menicon Expands Partnership with Optimed in North America.

Teva UK Limited Enters Wounds Sector With PolyHeal(TM) Launch

CASTLEFORD, England, November 15, 2010 – Teva UK Limited, a leading supplier of medicines to the NHS, has today
entered the Wound Care sector with the launch of PolyHeal (TM) at the Wounds
UK conference. PolyHeal is a product for hard-to-heal wounds and has been
clinically shown to result in a significant reduction in wound size after
just …. Original article  : Teva UK Limited Enters Wounds Sector With PolyHeal(TM) Launch.

APPG Hosts UK Event for World Pneumonia Day 2010 to Fight the World’s Leading Killer of Children Under Five

LONDON, November 15, 2010 – In support of World Pneumonia Day 2010, leaders in the fight
against pneumonia will gather in London on Tuesday 16 November for a
roundtable briefing from the All Party Parliamentary Group (APPG) for Global
Action Against Childhood Pneumonia. The meeting will highlight the progress
made since the inaugural World Pneumonia Day in 2009; …. Original source  : APPG Hosts UK Event for World Pneumonia Day 2010 to Fight the World's Leading Killer of Children Under Five.

Crystal Clear Health Literacy Awards 2011- Helping Your Patients Understand

DUBLIN, November 15, 2010 – The MSD/NALA Health Literacy Initiative is delighted to announce the
launch of the fourth Crystal Clear MSD Health Literacy Awards. Continuing to
gain momentum since their inaugural launch in 2007 the awards are designed to
recognise and reward excellence in health literacy in the healthcare sector.
Health Literacy is increasingly being recognised as …. Original article on Gaea Times at  : Crystal Clear Health Literacy Awards 2011- Helping Your Patients Understand.

Burcon and ADM Enter Into CLARISOY(R) Letter of Intent

VANCOUVER, November 15, 2010 – Burcon NutraScience Corporation (TSX – BU) ("Burcon") announced today
that it has signed a non-binding letter of intent (the "Letter of Intent")
with Archer Daniels Midland Company ("ADM") which details the intention of
the two parties to enter into a license agreement pursuant to which Burcon
will license (the "License") its CLARISOY(R) technology …. Original article  : Burcon and ADM Enter Into CLARISOY(R) Letter of Intent.

Chiltern Launches ‘Chiltern SAFE,’ a Comprehensive Global Trial Master File Management Solution

LONDON, November 15, 2010 – Chiltern International Limited (Chiltern), a global contract research
organization (CRO), announced the launch of Chiltern SAFE.

"Chiltern SAFE is revolutionizing records management for clinical trials,
stated Sarah Hitching, Chiltern Director, Records Management. "This complete
electronic Trial Master File (TMF) solution facilitates remote management of
documents, which saves administrative time and …. Read the original article  : Chiltern Launches 'Chiltern SAFE,' a Comprehensive Global Trial Master File Management Solution.

Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist

439 new Titles Span 24 Diverse Subject Areas Bringing SciVerse ScienceDirect Total to 12,500 eBooks

ST. LOUIS, November 15, 2010 – Elsevier, the leading publisher of scientific, technical and medical
information products and services, announced today its 2011 eBook collections
available for advance purchase and to be released on SciVerse ScienceDirect,
its online scientific knowledge platform. The 2011 [..] Read the original article: here.

iFuse Implant System(TM) Receives CE Mark

SI-BONE commences surgeon training at labs in Salzburg, Austria
SAN JOSE, California, November 15, 2010 – SI-BONE, Inc. (San Jose, California), a medical device company that is
pioneering the use of a minimally invasive surgical (MIS) device to treat the
sacroiliac (SI) joint announced today that it has received a CE mark for its
iFuse Implant System(TM). A …. Original article on Gaea Times at  : iFuse Implant System(TM) Receives CE Mark.

Ingenuity Systems and Sage Bionetworks Collaborate to Enable Predictive Disease Network Research

REDWOOD CITY, California, November 16, 2010 – Ingenuity(R) Systems, a leading provider of information solutions for
life science researchers, today announced a new collaboration with Sage
Bionetworks, a non-profit leader in predictive disease network research.
Under the collaboration, Sage will leverage IPA(R), Ingenuity's
industry-leading analysis software, and the Ingenuity(R) Knowledge Base of
structured biomedical Findings, to inform and enhance …. Original article  : Ingenuity Systems and Sage Bionetworks Collaborate to Enable Predictive Disease Network Research.

Edwards SAPIEN Transcatheter Heart Valve Demonstrates Substantial Improvement in Quality of Life in Inoperable Patients

IRVINE, California, November 16, 2010 – Edwards Lifesciences Corporation (NYSE: EW), the global leader in the
science of heart valves and hemodynamic monitoring, announced that in
addition to the improved survival seen in inoperable aortic stenosis patients
treated with the Edwards SAPIEN transcatheter heart valve in The PARTNER
Trial, a newly released analysis of the same patients shows [..] Read the original article: here.

Elsevier Launches SciVerse Applications Beta…Enabling the Research Community to Deliver a New Era in Scientific Search and Discovery

Release of Content APIs Empowers Developers to Create New Tools to Accelerate Science and Offers Platform for Sharing with the Global Scientific Community

AMSTERDAM, November 16, 2010 – Elsevier (www.elsevier.com) , a world-leading publisher of
scientific, technical and medical information products and services, today
announced the launch of SciVerse Applications beta, a new module within the
SciVerse platform … Read more >>.

IntraLinks Enhances Study Management Offering; Expands its Suite of SaaS-based Solutions for Clinical Operations

IntraLinks for Study Management Provides Unparalleled Automation and Insight Into Document-Centric Processes Throughout the Entire Clinical Trial Lifecycle

NEW YORK, November 16, 2010 – IntraLinks, a leading provider of critical information exchange
solutions, today announced IntraLinks for Study Management, a secure, online
platform for managing and monitoring all communication and activity with
investigative sites and other outside parties … Original article on : IntraLinks Enhances Study Management Offering; Expands its Suite of SaaS-based Solutions for Clinical Operations.

GRAVITAS Trial Shows That a Uniform Treatment Strategy of Doubling the Standard Dose of Plavix Does Not Improve Outcomes Post-PCI

Higher Cardiac Event Rates Seen in Patients with Higher Residual Platelet Reactivity, as Measured by the VerifyNow P2Y12 Test

SAN DIEGO, November 16, 2010 – Accumetrics, Inc., developer and marketer of the VerifyNow(R) System,
today announced that the GRAVITAS (Gauging Responsiveness With A VerifyNow
Assay-Impact On Thrombosis And Safety) Trial found that in patients with high
residual platelet … Read more : GRAVITAS Trial Shows That a Uniform Treatment Strategy of Doubling the Standard Dose of Plavix Does Not Improve Outcomes Post-PCI.

Isotechnika Reports Development, Distribution and Licencing Agreement and Private Placement Financing With ILJIN Life Science co., Ltd., Amendment of Arrangements With Paladin Labs Inc., and Related Matters

EDMONTON, Canada, November 16, 2010 – Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Corporation")
today announced that it has entered into a Development, Distribution and
License Agreement (the "DDL") with ILJIN Life Science Co., Ltd ("ILJIN") for
the further clinical and commercial development of voclosporin for use in
transplant indications applicable to voclosporin. Under the DDL in exchange
for … Read the original article on Gaea Times at : Isotechnika Reports Development, Distribution and Licencing Agreement and Private Placement Financing With ILJIN Life Science co., Ltd., Amendment of Arrangements With Paladin Labs Inc., and Related Matters.

Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device

First Ever CE Approved Combination Device is an Attractive Treatment for Coronary Artery Diseases

HELMOND, The Netherlands, November 16, 2010 – Blue Medical today announced that the company received CE Mark approval
for Blue Medical science based Drug Eluting Balloon (DEB) and simultaneously
for Blue Medical's coronary CoCr stent mounted on a Drug Eluting Balloon
(CoCr Stent on …. Source article  : Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device.

SuperSonic Imagine Announces That Gordon Waldron Has Been Named Executive Vice President and CFO

AIX-EN-PROVENCE, France, November 16, 2010 – SuperSonic Imagine, the innovative ultrasound medical imaging company, is
pleased to announce Gordon Waldron has been named as Executive Vice President
and CFO. As a member of the board of directors, he will be responsible for
driving all of SuperSonic Imagine's key strategic and commercial partnerships
as well as overseeing the company's …. Source article  : SuperSonic Imagine Announces That Gordon Waldron Has Been Named Executive Vice President and CFO.

Cardio3 BioSciences Announces Positive Outcome of the C-Cure(R) Phase II Clinical Trial in Heart Failure Patients

MONT-SAINT-GUIBERT, Belgium, November 17, 2010 – The Belgian biotechnology company, Cardio3 BioSciences – a
leader in discovery and development of regenerative and protective therapies
for the treatment of cardiovascular diseases – today announces positive
six-month results, including significant functional and clinical benefit,
from the Phase II clinical trial of its development programme C-Cure(R),
designed as a novel stem cell … Read this article on Gaea Times at : Cardio3 BioSciences Announces Positive Outcome of the C-Cure(R) Phase II Clinical Trial in Heart Failure Patients.

Mollie’s Fund Launches App for Skin Cancer Awareness

GARDEN CITY, New York, November 17, 2010 – The Mollie Biggane Melanoma Foundation, www.molliesfund.org has
announced the launch of a free application that will provide valuable
information for skin cancer and melanoma detection. This free application is
available on iPhone, iPod Touch and the iPad. It can also be downloaded
through iTunes.

Mollie's Fund, with …. Source article  : Mollie's Fund Launches App for Skin Cancer Awareness.

Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session

A Second AHA Presentation Includes Mouse Model Data Showing Plaque Reduction.

CHICAGO, November 17, 2010 – Resverlogix Corp. ("Resverlogix") (TSX:RVX) announces its top line
results of the ASSERT Phase 2 clinical trial which will be highlighted at the
prestigious American Heart Association Scientific Sessions 2010 Late Breaking
Clinical Trial session, by principal investigator Dr. Stephen Nicholls of the
Cleveland … Read this article on Gaea Times at : Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session.

Skin Rashes Caused by the use of Latex Gloves in Hospitals Soon to Become a Thing of the Past

DUSSELDORF, Germany, November 18, 2010 – A new technology is set to reduce the allergic potential of latex gloves
to virtually zero. Developed by the Dutch company Budev, the patented MPXXTM
technology is used to wash latex during manufacture. The new process and the
Cleantexx brand gloves made with it will be introduced at the MEDICA trade
fair … Read the original article on Gaea Times at : Skin Rashes Caused by the use of Latex Gloves in Hospitals Soon to Become a Thing of the Past.

UK Court of Appeal Publishes Decision in NPWT Case

Smith and Nephew Remains Committed to NPWT Market; will Continue to Serve Patients in United Kingdom

HULL, England, November 18, 2010 – The English Court of Appeal has published a decision in the long-running
dispute between KCI and Smith & Nephew relating to Negative Pressure Wound
Therapy (NPWT). The full implications of the decision will be finalized … Original source on Gaea Times at : UK Court of Appeal Publishes Decision in NPWT Case.

Elsevier Launches HESI QuizMe Nursing App Series

Customizable Quiz Apps for iPhone(R) and iPod touch(R) Help Students Build Nursing Knowledge

PHILADELPHIA, November 18, 2010 – Elsevier (www.elsevier.com/wps/find/homepage.cws_home), the
leading publisher of scientific, technical and medical information products
and services, today announced that the new HESI QuizMe app series for nursing
students is available from the Apple App Store. These apps familiarize
nursing students with clinically based … Read more »»».

Philips and Atom Medical Corporation Announce Strategic Alliance to Provide a Complete Neonatal and Perinatal Offering

ANDOVER, Massachusetts, November 18, 2010 – Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Atom Medical
Corporation, a major manufacturer of neonatal medical equipment, announced
today that they are expanding their relationship to serve customers with a
more complete portfolio of perinatal care solutions. This alliance now
includes neonatal patient monitoring, apnea home monitoring, neonatal
incubators and warmers, jaundice …. Original article  : Philips and Atom Medical Corporation Announce Strategic Alliance to Provide a Complete Neonatal and Perinatal Offering.

BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States

ccNexfin has an Unique Offering With Totally Noninvasive Beat-to-Beat Blood Pressure (BP), Cardiac Output (CO), and Masimo's Breakthrough Noninvasive Hemoglobin and Oxygen Saturation Measurements

AMSTERDAM, November 18, 2010 – BMEYE B.V., the innovators of combined totally noninvasive, beat-to-beat
blood pressure and cardiac output monitoring announces FDA clearance and the
United States launch of the BMEYE ccNexfin-the first …. Original article on Gaea Times at  : BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States.

DF Diary iPhone App Takes Diabetes Monitoring Mobile

MANCHESTER, England, November 18, 2010 – Diabetic Friend's DF Diary iPhone app is making monitoring food intake
much easier for those with diabetes. The application, designed by a Type 1
Diabetic, is powered by a comprehensive food database, incorporating dishes
from a growing number of restaurants. This enables users to quickly enter the
food they have eaten, thus …. Source  : Gaea News Network.

‘2010 China-Africa Brightness Action’ Launched in Beijing

Medical team heads for Africa via charter flight; about 1,000 cataract surgeries planned during one week

BEIJING, November 19, 2010 – The launching ceremony for the "2010 China-Africa Brightness
Action" was held at Deer Jet's fix base operation (FBO), Beijing Capital
International Airport on November 18. The charitable initiative, co-organized
by the China Association for Promoting Democracy (CAPD), …. Source  : Gaea News Network.

Boston Scientific Announces CE Mark Approval and First Implants for New Devices to Treat Heart Failure and Sudden Cardiac Death

NATICK, Massachusetts, November 19, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced CE
Mark approval of its INCEPTA(TM), ENERGEN(TM) and PUNCTUA(TM) cardiac
resynchronization therapy defibrillators (CRT-Ds) and implantable
cardioverter defibrillators (ICDs). They are the Company's latest devices to
treat heart failure and sudden cardiac death.

These next-generation products are designed to advance patient
care with … Read the original article on Gaea Times at : Boston Scientific Announces CE Mark Approval and First Implants for New Devices to Treat Heart Failure and Sudden Cardiac Death.